The name of the Alzheimer's drug Reminyl is being changed to Razadyne.
The reason for the name change is due to reported confusion and dispensing errors with a similarly named diabetes drug called Amaryl.
Click here to read the full press release from Johnson & Johnson.


One's first step in wisdom is to kuesteon everything - and one's last is to come to terms with everything.
Posted by: Lizette Tyler | August 21, 2007 at 05:02 AM